MHRA Class 3 Medicines Recall: Clonidine hydrochloride 50micrograms/5ml oral solution

MHRA Class 3 Medicines Recall: Clonidine hydrochloride 50micrograms/5ml oral solution

February 17, 2021

Class 3 Medicines recall: Clonidine hydrochloride 50micrograms/5ml oral solution (SyriMed) (previously known as Thame Laboratories Licensed Medicines Division)

Drug alert number: EL (21) A/05

Date issued: 17th February 2021

The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for:

Clonidine hydrochloride 50micrograms/5ml oral solution (SyriMed) PL 39307/0082

SyriMed are recalling the below batch as a precautionary measure due to an issue related to the container closure (child-lock cap). The Marketing Authorisation Holder has received a number of complaints related to defective container closures and the investigation has identified an issue with the bottle capping during the manufacturing process for the batch below only.

 

Batch Number Expiry Date Pack Size First Distributed
201014 September 2022 100ml 19th November 2020

Advice for healthcare professionals

  • Stop supplying the batches listed above immediately.
  • Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Full drug alert can be viewed here.

Company contacts for further information

For more information or medical information queries, please contact: customer.services@syrimed.co.uk.

 



Posted in:


More Latest News >

PQS: AMS virtual event now on-demand

Community pharmacy contractors can now access an online recording of the antimicrobial stewardship (AMS) virtual event, which was jointly hosted...

Evaluation of LFD tests

As part of meeting Medicines and Healthcare products Regulatory Agency (MHRA) obligations, the UK Health Security Agency (UKHSA) – of...